Nymox Pharmaceutical
NYMX
#9606
Rank
C$25.35 M
Marketcap
Country
$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Nymox Pharmaceutical (NYMX)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nymox Pharmaceutical from 1997 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A-100%
2020 C$0 M-95.76%
2019 C$0.15 M-63.12%
2018 C$0.4 M44.62%
2017 C$0.28 M-26.11%
2016 C$0.38 M-90.05%
2015 C$3.83 M11.91%
2014 C$3.42 M-4.27%
2013 C$3.57 M17.03%
2012 C$3.05 M-3.54%
2011 C$3.16 M357.47%
2010 C$0.69 M58.18%
2009 C$0.43 M-15.96%
2008 C$0.52 M20.43%
2007 C$0.43 M-15.63%
2006 C$0.51 M3.18%
2005 C$0.49 M28.38%
2004 C$0.38 M48.78%
2003 C$0.26 M-53.97%
2002 C$0.56 M50.87%
2001 C$0.37 M10.73%
2000 C$0.33 M-33.53%
1999 C$0.5 M10.1%
1998 C$0.46 M7.74%
1997 C$0.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$57.25 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$77.28 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$56.75 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$121.81 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA